SCHEMBL14301033

SCHEMBL14301033

CCOc1ccccc1OCCNCCc1ccc(OC)c(S(N)(=O)=O)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA1A P35348 8/20 0.70
▸ ADRA1D P25100 7/20 0.70
▸ ADRA1B P35368 7/20 0.70
▸ ADRB2 P07550 6/20 0.70
▸ DRD2 P14416 4/20 0.70
▸ DRD3 P35462 4/20 0.70
▸ HTR1A P08908 4/20 0.70
▸ ADRB1 P08588 2/20 0.70
▸ ADRA2A P08913 2/20 0.70
▸ ADRA2B P18089 2/20 0.70
▸ ADRA2C P18825 2/20 0.70
▸ HTR2A P28223 2/20 0.70
▸ HTR2B P41595 2/20 0.70
▸ KCNH2 Q12809 2/20 0.70
▸ HTR7 P34969 1/20 0.70
▸ OPRM1 P35372 1/20 0.70
▸ DRD1 P21728 2/20 0.58
▸ DRD4 P21917 2/20 0.58
▸ SIGMAR1 Q99720 2/20 0.49
▸ KMT2A Q03164 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9416163 0.94 ADRB2 (0.65) ADRA1AADRA1DADRA1BADRB2DRD2
Hydrochloric Acid SCHEMBL9123410 0.93 ADRB2 (0.64) ADRA1AADRA1DADRA1BADRB2DRD2
SCHEMBL9416157 0.88 ADRA1A (0.54) ADRA1AADRA1DADRA1BADRB2DRD2
Hydrochloric Acid SCHEMBL9123221 0.87 ADRA1A (0.53) ADRA1AADRA1DADRA1BADRB2DRD2
SCHEMBL9125314 0.86 ADRB2 (0.73) ADRA1AADRA1DADRA1BADRB2DRD2
SCHEMBL9416152 0.86 ADRA1A (0.65) ADRA1AADRA1DADRA1BADRB2DRD2
Hydrochloric Acid SCHEMBL9124065 0.85 ADRA1A (0.64) ADRA1AADRA1DADRA1BADRB2DRD2
SCHEMBL9632507 0.85 ADRB2 (0.53) ADRA1AADRA1DADRA1BADRB2DRD2
SCHEMBL19068575 0.82 ADRA1A (0.81) ADRA1AADRA1DADRA1BADRB2DRD2
Tamsulosin SCHEMBL53998 0.82 ADRA1A (1.00) ADRA1AADRA1DADRA1BADRB2DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170268028-A1 ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT 2017-09-21 — — US disclosed
US-9695451-B2 Polynucleotides encoding engineered imine reductases CODEXIS, INC. (US) 2017-07-04 — — US disclosed
EP-1891954-A2 Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder Takeda Pharmaceutical Company Limited (JP) 2008-02-27 — — EP disclosed
Send feedback